Thyrocare Technologies Ltd. NSE: THYROCARE | BSE: 539871

Strong Performer, Getting Expensive

Download real time

1085.45 3.60 (0.33%)

New 52W High in past week

56,532

NSE+BSE Volume

NSE 11 Jul, 2025 3:31 PM (IST)

Dividend

Thyrocare Technologies Ltd. has an upcoming dividend of ₹21.00 per share due on 25 Jul 2025 See details

Thyrocare Technologies Ltd. share price target

Name: Latest research reports of Thyrocare Technologies Ltd. authored by AUM Capital and published by - Trendlyne research reports.
Item: Thyrocare Technologies Ltd.
Rating: 5
Author: AUM Capital

Thyrocare Technologies Ltd. has an average share price target of 1000. The consensus estimate represents a downside of -7.87% from the last price of 1085.45. View 2 reports from 1 analysts offering long-term price targets for Thyrocare Technologies Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
13 Jul 2025	Thyrocare Tech	Consensus Share Price Target	1085.45	1125.00	-	3.64	buy	pdf Detailed Estimates
22 Apr 2016	Thyrocare Tech	AUM Capital	1085.45				IPO Subscribe	pdf post cache	Broker Report Thyrocare Technologies Ltd AUM Capital Thyrocare Technologies Limited (TTL) is one of the leading fully automated diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. Under its Aarogyam' brand it provides 16 profiles of tests which offer patients a suite of wellness and preventive health care tests. It operates with a Centralized Processing Laboratory (CPL) in Mumbai for esoteric tests and Regional Processing Laboratory (RPL) in major metros of India and other parts of Asia. The... pdf Copy Link Share on Share on Share on Share on Alert
22 Apr 2016	Thyrocare Tech	Ashika Research	1085.45				IPO Subscribe	pdf post cache	Broker Report Thyrocare Technologies Ltd. Ashika Research The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 10,744,708 Equity Shares by the Selling Shareholders (up to 10,207,472 Eq Sh by Agalia; up to 180,000 Eq Sh by A. Sundararaju HUF; up to 180,000 Eq Sh by A. Velumani HUF and up to 177,236 Eq Sh by Anand Velumani). The Company will not receive any proceeds of the... pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

New 52W High in past week

Thyrocare Technologies Ltd. share price target

Thyrocare Technologies Ltd. has an average share price target of 1000. The consensus estimate represents a downside of -7.87% from the last price of 1085.45. View 2 reports from 1 analysts offering long-term price targets for Thyrocare Technologies Ltd..

Thyrocare Technologies Ltd

Thyrocare Technologies Ltd.

Advisor Screeners